Longitudinal imaging: change and causality
暂无分享,去创建一个
[1] Jennifer L. Whitwell,et al. Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease , 2008, NeuroImage.
[2] Rebecca S. N. Liu,et al. The structural consequences of newly diagnosed seizures , 2002, Annals of neurology.
[3] Gary A. Ford,et al. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure , 2007, Journal of Neurology.
[4] Hiroaki Kazui,et al. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? , 2005, The American journal of psychiatry.
[5] Jan Hillert,et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. , 2007, Journal of neurology, neurosurgery, and psychiatry.
[6] Nick C Fox,et al. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis , 2006, Journal of magnetic resonance imaging : JMRI.
[7] Nick C Fox,et al. Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.
[8] Marco Battaglini,et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.
[9] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[10] Alexander Hammers,et al. Progressive neocortical damage in epilepsy , 2003, Annals of neurology.
[11] John Ashburner,et al. A tensor based morphometry study of longitudinal gray matter contraction in FTD , 2007, NeuroImage.
[12] Marco Rovaris,et al. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX , 2007, Journal of magnetic resonance imaging : JMRI.
[13] Sharon E. Lee,et al. Cerebral Ventricular Changes Associated With Transitions Between Normal Cognitive Function, Mild Cognitive Impairment, and Dementia , 2007, Alzheimer disease and associated disorders.
[14] D. Miller,et al. Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study , 2007, Multiple sclerosis.
[15] M. Könönen,et al. Hippocampal damage in newly diagnosed focal epilepsy , 2005, Neurology.
[16] J. Carel. Treatment of Children Born Short for Gestational Age: A European Perspective , 2005, Hormone Research in Paediatrics.
[17] Martola Juha,et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[18] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[19] C. Jack,et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.
[20] C. Jack,et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI , 2008, Neurobiology of Aging.
[21] S. Schuchmann,et al. Recurrent seizures do not cause hippocampal damage , 2004, Journal of Neurology.
[22] V. M. Anderson BSc,et al. Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: Sample size estimates , 2007, Journal of Neurology.
[23] Louis Lemieux,et al. Cerebral Damage in Epilepsy: A Population‐based Longitudinal Quantitative MRI Study , 2005, Epilepsia.
[24] Aashit Shah,et al. Hippocampal sclerosis is a progressive disorder: A longitudinal volumetric MRI study , 2003, Annals of neurology.
[25] J. Ashburner,et al. Atrophy progression in semantic dementia with asymmetric temporal involvement: A tensor-based morphometry study , 2009, Neurobiology of Aging.
[26] M. Mintun,et al. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. , 2008, Archives of neurology.
[27] J. Ranjeva,et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum , 2007, Multiple sclerosis.
[28] Frederik Barkhof,et al. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. , 2007, Archives of neurology.
[29] Clifford R Jack,et al. Rates of cerebral atrophy differ in different degenerative pathologies. , 2006, Brain : a journal of neurology.
[30] Paul Edison,et al. Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study , 2006, Annals of neurology.
[31] C. Guttmann,et al. MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability , 2007, American Journal of Neuroradiology.
[32] Daniel Bandy,et al. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. , 2007, The American journal of psychiatry.
[33] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[34] Ari Syngeniotis,et al. Seizure‐associated hippocampal volume loss: A longitudinal magnetic resonance study of temporal lobe epilepsy , 2002, Annals of neurology.
[35] Nick C Fox,et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study , 2006, The Lancet Neurology.
[36] Nick C. Fox,et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.
[37] C. Jack,et al. Atrophy rates accelerate in amnestic mild cognitive impairment , 2008, Neurology.
[38] Nick C Fox,et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.
[39] Nick C Fox,et al. Longitudinal Patterns of Regional Change on Volumetric MRI in Frontotemporal Lobar Degeneration , 2004, Dementia and Geriatric Cognitive Disorders.
[40] Nick C Fox,et al. Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.
[41] Owen Carmichael,et al. TRAJECTORIES OF BRAIN LOSS IN AGING AND THE DEVELOPMENT OF COGNITIVE IMPAIRMENT , 2009, Neurology.
[42] Stephen M. Smith,et al. Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis , 2007, NeuroImage.
[43] Clifford R. Jack,et al. 3 D maps frommultiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer ’ s disease , 2007 .
[44] Richard J. Caselli,et al. Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates , 2007 .
[45] Karen M Rodrigue,et al. Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. , 2007, Neuropsychology.
[46] Nick C Fox,et al. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment , 2007, Neurology.
[47] Nick C Fox,et al. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study , 2003, The Lancet.
[48] Nick C Fox,et al. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. , 2003, Archives of neurology.
[49] M. Ron,et al. Cognitive impairment in relapsing—remitting multiple sclerosis can be predicted by imaging performed several years earlier , 2008, Multiple sclerosis.
[50] Michael W Weiner,et al. Longitudinal MRI and cognitive change in healthy elderly. , 2007, Neuropsychology.
[51] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[52] Amy J. Jak,et al. Differential Cross-Sectional and Longitudinal Impact of APOE Genotype on Hippocampal Volumes in Nondemented Older Adults , 2007, Dementia and Geriatric Cognitive Disorders.
[53] Owen Carmichael,et al. Acceleration of cerebral ventricular expansion in the Cardiovascular Health Study , 2007, Neurobiology of Aging.
[54] R. Buckner,et al. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD , 2005, Neurology.
[55] C. Jack,et al. β‐amyloid burden is not associated with rates of brain atrophy , 2008, Annals of neurology.
[56] J. Quinn,et al. Changes in premorbid brain volume predict Alzheimer’s disease pathology , 2003, Neurology.
[57] J. L. Cox,et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[58] Chris Frost,et al. Cerebral Atrophy Measurement in Clinically Isolated Syndromes and Relapsing Remitting Multiple Sclerosis: A Comparison of Registration‐Based Methods , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.